Kirk E Evoy

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Colorectal Cancer Screening

Cross Sectional

Spinal Cord Injury

Top Venues

The mental health clinician

Substance abuse : research and treatment

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Kirk E Evoy, Shelby R Humpert, Sorina B Torrez, Haneen Hussein, Jordan R Covvey
Quetiapine and olanzapine misuse prevalence in a US general population sample. The mental health clinician 13 (2) (2023)
Alyssa C Eaves, Chengwen Teng, Kirk E Evoy, Christopher Raymond Frei
Retrospective Cohort Evaluating the Comparative Effectiveness of Ceftaroline and Daptomycin as First-Line Therapies for Inpatient Treatment of Diabetic Foot Infection in the United States Veterans Health Care System. Drugs - real world outcomes 9 (4) (2022)
Erica L Torres, Kirk E Evoy, Lindsay O Thomas
Outpatient Opioid and Naloxone Prescribing Practices at an Academic Medical Center during the COVID-19 Pandemic. Journal of pain & palliative care pharmacotherapy 36 (3) (2022)
Alyssa M Peckham, Jordan R Covvey, Kirk E Evoy
Letter to the Editor: Comment on "Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth". Pain and therapy 10 (1) (2021)
Kirk E Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R Covvey, Alyssa M Peckham, Megan D Morrison
Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update. Drugs 81 (1) (2021)
Kirk E Evoy, Lucas G Hill, Corey S Davis
Considering the Potential Benefits of Over-the-Counter Naloxone. Integrated pharmacy research & practice 10 (2021)
Kirk E Evoy, Jordan R Covvey, Alyssa M Peckham, Kelly R Reveles
Gabapentinoid misuse, abuse and non-prescribed obtainment in a United States general population sample. International journal of clinical pharmacy 43 (4) (2021)
Kirk E Evoy, Sarvnaz Sadrameli, Jillian Contreras, Jordan R Covvey, Alyssa M Peckham
Authors' Reply to Bonnet et al. "Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update". Drugs 81 (5) (2021)
Payal H Desai, Olesya Taylor, Kunal J Shah, Kirk E Evoy, Alyssa M Peckham
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids. The mental health clinician 11 (4) (2021)
Lucas G Hill, Lindsey J Loera, Kirk E Evoy, Mandy L Renfro, Sorina B Torrez, Claire M Zagorski, Joshua C Perez, Shaun M Jones, Kelly R Reveles
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Texas, USA. Addiction (Abingdon, England) 116 (6) (2020)
Jordan R Covvey, Samantha M Vogel, Alyssa M Peckham, Kirk E Evoy
Prevalence and characteristics of self-reported kratom use in a representative US general population sample. Journal of addictive diseases 38 (4) (2020)
Kirk E Evoy, Charles E Leonard, Jordan R Covvey, Leslie Ochs, Alyssa M Peckham, Samantha Soprano, Kelly R Reveles
Receipt of Substance Use Counseling Among Ambulatory Patients Prescribed Opioids in the United States. Substance abuse : research and treatment 14 (2020)
Marilyn L Mootz, Rachel S Britt, Allison A Mootz, Grace C Lee, Kelly R Reveles, Kirk E Evoy, Chengwen Teng, Christopher Raymond Frei
Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System. Hospital practice (1995) 47 (4) (2019)
Alyssa M Peckham, Kirk E Evoy, Jordan R Covvey, Leslie Ochs, Kathleen A Fairman, David A Sclar
Predictors of Gabapentin Overuse With or Without Concomitant Opioids in a Commercially Insured U.S. Population. Pharmacotherapy 38 (4) (2018)